Advisor Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $1K | Hold |
291
| – | – | ﹤0.01% | 5049 |
|
|
2019
Q3 | $1K | Hold |
291
| – | – | ﹤0.01% | 5050 |
|
|
2019
Q2 | $1K | Hold |
291
| – | – | ﹤0.01% | 5060 |
|
|
2019
Q1 | $1K | Sell |
291
-3
| -1% | -$10 | ﹤0.01% | 5025 |
|
|
2018
Q4 | $1K | Sell |
294
-747
| -72% | -$2.54K | ﹤0.01% | 4920 |
|
|
2018
Q3 | $7K | Hold |
1,041
| – | – | ﹤0.01% | 4432 |
|
|
2018
Q2 | $8K | Buy |
1,041
+495
| +91% | +$3.8K | ﹤0.01% | 4167 |
|
|
2018
Q1 | $19K | Buy |
546
+7
| +1% | +$244 | ﹤0.01% | 3700 |
|
|
2017
Q4 | $24K | Sell |
539
-838
| -61% | -$37.3K | ﹤0.01% | 3585 |
|
|
2017
Q3 | $59K | Buy |
1,377
+30
| +2% | +$1.29K | ﹤0.01% | 2820 |
|
|
2017
Q2 | $50K | Sell |
1,347
-343
| -20% | -$12.7K | ﹤0.01% | 2852 |
|
|
2017
Q1 | $91K | Buy |
1,690
+1,132
| +203% | +$61K | ﹤0.01% | 2229 |
|
|
2016
Q4 | $30K | Buy |
558
+344
| +161% | +$18.5K | ﹤0.01% | 2967 |
|
|
2016
Q3 | $13K | Sell |
214
-4
| -2% | -$243 | ﹤0.01% | 3398 |
|
|
2016
Q2 | $13K | Buy |
+218
| New | +$13K | ﹤0.01% | 3317 |
|